[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2002042422A3 - Interactions moleculaires dans des cellules hematopoietiques - Google Patents

Interactions moleculaires dans des cellules hematopoietiques Download PDF

Info

Publication number
WO2002042422A3
WO2002042422A3 PCT/US2001/044138 US0144138W WO0242422A3 WO 2002042422 A3 WO2002042422 A3 WO 2002042422A3 US 0144138 W US0144138 W US 0144138W WO 0242422 A3 WO0242422 A3 WO 0242422A3
Authority
WO
WIPO (PCT)
Prior art keywords
hematopoietic cells
molecular interactions
cells
reagents
methods
Prior art date
Application number
PCT/US2001/044138
Other languages
English (en)
Other versions
WO2002042422A2 (fr
Inventor
Peter Lu
Joshua D Rabinowitz
Johannes Schweizer
Original Assignee
Arbor Vita Corp
Peter Lu
Joshua D Rabinowitz
Johannes Schweizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Vita Corp, Peter Lu, Joshua D Rabinowitz, Johannes Schweizer filed Critical Arbor Vita Corp
Priority to AU2002239336A priority Critical patent/AU2002239336A1/en
Priority to EP01987086A priority patent/EP1387692A4/fr
Publication of WO2002042422A2 publication Critical patent/WO2002042422A2/fr
Publication of WO2002042422A3 publication Critical patent/WO2002042422A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des réactifs et des procédés servant à inhiber ou à amplifier des interactions entre des protéines dans des cellules hématopoïétiques ou d'autres cellules jouant un rôle dans la transmission d'une réponse immune. Ces réactifs et ces procédés sont utiles pour traiter une variété de maladies et d'états pour lesquels les cellules du système immunitaire jouent un rôle d'intermédiaire.
PCT/US2001/044138 2000-11-10 2001-11-09 Interactions moleculaires dans des cellules hematopoietiques WO2002042422A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002239336A AU2002239336A1 (en) 2000-11-10 2001-11-09 Molecular interactions in hematopoietic cells
EP01987086A EP1387692A4 (fr) 2000-11-11 2001-11-09 Interactions moleculaires dans des cellules hematopoietiques

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US09/710,059 2000-11-10
US71005900A 2000-11-11 2000-11-11
US72206900A 2000-11-24 2000-11-24
US72191500A 2000-11-24 2000-11-24
US09/721,915 2000-11-24
US09/722,069 2000-11-24
US72455300A 2000-11-28 2000-11-28
US09/724,553 2000-11-28

Publications (2)

Publication Number Publication Date
WO2002042422A2 WO2002042422A2 (fr) 2002-05-30
WO2002042422A3 true WO2002042422A3 (fr) 2003-08-14

Family

ID=27505517

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/044138 WO2002042422A2 (fr) 2000-11-10 2001-11-09 Interactions moleculaires dans des cellules hematopoietiques

Country Status (3)

Country Link
EP (1) EP1387692A4 (fr)
AU (1) AU2002239336A1 (fr)
WO (1) WO2002042422A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
EP1642135A1 (fr) * 2003-06-06 2006-04-05 AstraZeneca AB Methode de diagnostic de maladies inflammatoires intestinales
US7410950B2 (en) 2004-04-01 2008-08-12 Board Of Regents, The University Of Texas System Peptides of CaV2.2 that inhibit pain
KR101236450B1 (ko) 2004-12-21 2013-02-25 무스크 파운데이션 포 리서치 디벨롭먼트 상처 치유 및 조직 재생을 촉진하기 위한 조성물 및 방법
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
AU2012202117B2 (en) * 2004-12-21 2014-06-26 Musc Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
US8633160B2 (en) 2005-12-30 2014-01-21 Nono Inc. Small molecule inhibitors of PDZ interactions
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
KR102038948B1 (ko) 2012-03-01 2019-11-26 퍼스트스트링 리서치 인코포레이티드 알파 코넥신 c-말단 (act) 펩타이드를 포함하는 국소 겔
WO2015073913A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
CN106232800B (zh) 2014-03-25 2020-07-03 泰尔茂比司特公司 介质的被动替代
AU2015305269B2 (en) 2014-08-22 2021-12-23 Auckland Uniservices Limited Channel modulators
EP3198006B1 (fr) 2014-09-26 2021-03-24 Terumo BCT, Inc. Alimentation programmée
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
JP7034949B2 (ja) 2016-05-25 2022-03-14 テルモ ビーシーティー、インコーポレーテッド 細胞の増殖
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509064A (ja) * 1993-09-22 1996-09-24 デイド、インターナショナル、インコーポレイテッド 化学的に架橋したタンパクの固相支持体上の固定化

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FAULKNER G. ET AL.: "A new Z-band alternatively spliced PDZ-motif protein", THE JOURNAL OF CELL BIOLOGY, vol. 146, no. 2, 26 July 1999 (1999-07-26), pages 465 - 475, XP002958709 *
See also references of EP1387692A4 *
VALLENIUS T. ET AL.: "CLP-36 PDZ-LIM protein associates with nonmuscle alpha-actinin-1 and alpha-actinin-4", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, no. 15, 14 April 2000 (2000-04-14), pages 11100 - 11105, XP002958708 *
WECHSLER A. ET AL.: "Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin", THE EMBO JOURNAL, vol. 17, no. 14, 1998, pages 3931 - 3939, XP002958710 *
XIA H. ET AL.: "Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs", THE JOURNAL OF CELL BIOLOGY, vol. 139, no. 2, October 1997 (1997-10-01), pages 507 - 515, XP002958711 *

Also Published As

Publication number Publication date
EP1387692A4 (fr) 2004-07-21
EP1387692A2 (fr) 2004-02-11
AU2002239336A1 (en) 2002-06-03
WO2002042422A2 (fr) 2002-05-30

Similar Documents

Publication Publication Date Title
WO2000069896A3 (fr) Interactions moleculaires dans les cellules hematopoietiques
WO2002042422A3 (fr) Interactions moleculaires dans des cellules hematopoietiques
WO2003014303A3 (fr) Interactions moleculaires dans les cellules
WO2002072605A3 (fr) Technique d'expression pour des proteines contenant un fragment d'anticorps isotype chimerique
EP1288299A3 (fr) Synthétase ARNt
AU7097400A (en) Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof
WO2001018248A3 (fr) Signalisation de detection de quorum chez des bacteries
EP1462525A4 (fr) Systeme d'expression d'arnsi et procede de production de cellule knockdown a gene fonctionnel ou analogue utilisant ce systeme
WO2003050260A3 (fr) Fusions de genes exprimees par la streptavidine et leurs procedes d'utilisation
WO1999020747A3 (fr) NOUVELLE KINASE HUMAINE POINT DE CONTROLE, hCDS1, COMPOSITIONS ET METHODES ASSOCIEES
WO2001096604A3 (fr) Analyse de polymorphismes genetiques a l'aide de marqueurs detectables a la lumiere diffusee
WO2004013290A3 (fr) Compositions et procedes applicables a la biologie moleculaire
AU1728001A (en) Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample
WO2002062957A3 (fr) Compositions et methodes de biologie moleculaire
EP0821693A4 (fr) Nouvelles sequences d'adn du cytomegalovirus humain
AU2001238212A1 (en) Modified fluorescent proteins
WO2001049721A3 (fr) Nouveaux genes bacteriens et proteines qui sont essentielles pour la viabilite cellulaire et leurs utilisations
WO2002031512A3 (fr) Interactions moleculaires dans des cellules hematopoietiques
CA2361987A1 (fr) Proteine de liaison a l'antigene du syndrome de goodpasture
DE69634077D1 (de) Haemophilus adhäsionsproteinen
WO2000069898A3 (fr) Interactions moleculaires dans les reactions allergiques
WO2001066752A3 (fr) Genes specifiques de la reproduction
AU2001256232A1 (en) Genes isolated from dendritic cells, gene products and methods employing the same
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
AU3556800A (en) Expression of dna or proteins in (c. elegans)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001987086

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001987086

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP